2023 Fiscal Year Final Research Report

Management criteria of peripheral intravenous catheter placement for preventing catheter failure: Development and spreading with the Japanese version

Research Project

PDF

Project/Area Number	20H03976
Research Category	Grant-in-Aid for Scientific Research (B)
Allocation Type	Single-year Grants
Section	一般
Review Section	Basic Section 58060:Clinical nursing-related
Research Institution	Fujita Health University (2022-2023) The University of Tokyo (2020-2021)
Principal Investigator	Murayama Ryoko 藤田医科大学, 保健衛生学部, 教授 (10279854)
Co-Investigator(Kenkyū-buntansha)	真田弘美石川県立看護大学, 看護学部, 教授 (50143920) 土井麻里 (阿部麻里) 東京大学, 大学院医学系研究科(医学部), 助教 (50802386) 小見山智恵子東京大学, 医学部附属病院, 看護部長 (60581634)
Project Period (FY)	2020-04-01 – 2024-03-31
Keywords	末梢静脈カテーテル留置 / 輸液療法 / 輸液看護 / 看護技術 / 超音波検査装置
Outline of Final Research Achievements	Selection of a large vessel, successful completion of the first puncture, and fixation of the catheter tip in the appropriate position are essential for prevention of catheter failure. Our previous study demonstrated that these requirements can be met by use of ultrasonography. We developed a catheter that could be placed in the upper arm vein and demonstrated its effectiveness. Furthermore, Best Practices for Catheter Placement Techniques Using Ultrasonography was developed and published. The pilot study aimed on safety management during chemotherapy as a target for the dissemination of this practice for catheter placement. A pre-post comparison trial was employed to identify factors associated with promoting or impeding the dissemination of this technology. Furthermore, implementation strategies were developed to incorporate ultrasonography into safe infusion therapy management standards.
Free Research Field	臨床看護学
Academic Significance and Societal Importance of the Research Achievements	点滴治療を完了させるためには、カテーテル留置に伴う有害事象の発症の予防が求められた。そのため産学連携により上腕の血流量の多い血管に留置できるカテーテルを開発し、その有効性を検証した。点滴トラブル予防のためのデバイス選択の一助になったと考える。さらに有害事象発症の原因である血管壁の損傷を最小限とするため、エコーを活用するカテーテル留置技術を開発しその普及を試みた。普及により患者の苦痛低減、医療者の負担軽減、医療経済的な損失の減少につながることが実証可能となり、点滴トラブル発症ゼロにむけた管理基準作成に向けて大きく前進したと考える。